Jubilant Flame International, LTD. financials

JFIL CIK 0001517389

Source: EDGAR filings · Built 2026-06-19T01:06:34Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Working Capital -1.42M -1.36M -1.30M -1.23M -1.17M -1.12M
Return on Equity (ROE) 4.47% 4.40% 5.19% 5.01% 5.55% 7.52%
Return on Assets (ROA) -392.26% -461.68% -534.86% -431.99% -460.24% -404.25%
Current Ratio 0.01× 0.01× 0.01× 0.01× 0.01× 0.02×
Effective Tax Rate 0.00% 0.00%
Cash Conversion Ratio 0.78× 1.17× 0.95× 0.65× 0.61× 0.82×
Accruals Ratio -0.88× 0.79× -0.28× -1.50× -1.78× -0.71×

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 0 0
Revenues 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0
Selling, General and Administrative Expense 59.67K 67.36K 61.55K 79.27K
Operating Expenses 67.36K 61.55K 79.27K 84.19K
Operating Income (Loss) -59.67K -67.36K -61.55K -64.81K -84.19K
Income Tax Expense (Benefit) 0 0 0 0 0
Net Income (Loss) Attributable to Parent -63.51K -59.67K -67.36K -61.55K -64.81K -84.19K
Earnings Per Share, Diluted $0.00 $0.00 $0.00
Weighted Average Number of Shares Outstanding, Diluted 19.99M 19.99M 19.99M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 3.58K 3.58K 2.44K
Assets, Current 16.19K 12.93K 12.60K 14.25K 14.08K 20.82K
Assets 16.19K 12.93K 12.60K 14.25K 14.08K 20.82K
Liabilities, Current 1.44M 1.37M 1.31M 1.24M 1.18M 1.14M
Liabilities 1.44M 1.37M 1.31M 1.24M 1.18M 1.14M
Stockholders' Equity Attributable to Parent -1.42M -1.36M -1.30M -1.23M -1.17M -1.12M
Common Stock, Shares, Outstanding 19.99M 19.99M 19.99M 19.99M 19.99M 19.55M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities -49.26K -69.82K -63.89K -40.13K -39.68K -69.37K
Net Cash Provided by (Used in) Investing Activities 0 0
Net Cash Provided by (Used in) Financing Activities 52.21K 69.70K 61.65K 40.13K 40.82K 61.18K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (JFIL CIK 0001517389), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ATEKU

ATHENA TECHNOLOGY ACQUISITION CORP. II

HHS

HARTE HANKS, INC.

RENXF

Renalytix plc